Loading icon

The Tangled Web: Protein Misfolding in Neurodegenerative Diseases

Post banner image
Share:

Protein misfolding, a process where proteins deviate from their proper folding pathways, can have profound clinical impacts, particularly in the context of complex diseases like multiple sclerosis and other neurodegenerative conditions. The process of misfolding might occur spontaneously and is more likely in proteins with repetitive amino acid motifs, such as polyglutamine in Huntington's disease. Misfolded proteins can transition into toxic configurations, which can catalyze the same toxic transformation in their native counterparts, creating a self-sustaining loop of toxicity. This phenomenon is exemplified in prion proteins, which are known for their role in transmissible spongiform encephalopathies like mad cow disease and Creutzfeldt-Jakob disease in humans​​.

The progression of neurodegenerative diseases such as Alzheimer's and Parkinson's is heavily associated with the accumulation of misfolded proteins. These conditions can be either sporadic or familial, with the risk of development increasing significantly with age. This increase in risk is partly due to age-related disturbances in the synthesis, folding, and degradation balance of proteins, leading to an accumulation of misfolded proteins. Additionally, environmental factors such as exposure to substances that damage the mitochondria can increase the risk of these diseases. Genetic factors also play a crucial role, as mutations in various genes have been linked to different neurodegenerative diseases​​.

Prion-like mechanisms have been observed in a range of neurodegenerative diseases, where the propagation of misfolded proteins can act in an infective manner. For example, studies have shown that synthetic amyloid-related peptides can induce amyloidosis in mice, suggesting a prion-like transmission mechanism in non-prion protein misfolding diseases. This expands the concept of prion propagation to a broader range of neurodegenerative conditions​​.

Moreover, the impact of protein misfolding is not limited to the central nervous system. Diseases like type 2 diabetes, inherited cataracts, and certain forms of atherosclerosis also involve the misfolding and aggregation of proteins. These diseases typically feature the expression of proteins in abnormal contexts, leading to irreversible changes and aggregation. The resulting protein aggregates can be due to various causes, including genetic mutations, imbalances in protein concentration, and defects in cellular mechanisms responsible for protein degradation​​.

In summary, protein misfolding and aggregation play a critical role in the pathogenesis of various complex diseases, particularly neurodegenerative conditions. The mechanisms involved in these processes are complex and involve a combination of genetic, environmental, and age-related factors. Understanding these mechanisms is crucial for developing effective treatments and preventive strategies for these debilitating diseases.

Reference:

Reynaud, E. (2010). Protein misfolding and degenerative diseases. Nature Education, 3(9), 28.
Soto, C., & Pritzkow, S. (2018). Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nature neuroscience, 21(10), 1332-1340.